In both studies, blockade of CTLA-4 or PD-1 reduced tumor vascular density, improved vessel perfusion, and alleviated tumor tissue hypoxia, all of which were marks of the vascular normalization effect. The gene discussed is CTLA4; the disease is neoplasm.